{"published":"2021-10-27 23:20:28","blog_title":"\u81a0\u539f\u75c5\u30fb\u30ea\u30a6\u30de\u30c1\u4e00\u4eba\u6284\u8aad\u4f1a","author_name":"CTD_GIM","title":"\u96e3\u6cbb\u6027SLE\u3078\u306eRituximab+Belimumab\u4f75\u7528\u7642\u6cd5\uff08BEAT-LUPUS\uff09","categories":["SLE","\u6cbb\u7642\u85ac"],"type":"rich","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fctd-gim.hatenablog.com%2Fentry%2F2021%2F10%2F27%2F232028\" title=\"\u96e3\u6cbb\u6027SLE\u3078\u306eRituximab+Belimumab\u4f75\u7528\u7642\u6cd5\uff08BEAT-LUPUS\uff09 - \u81a0\u539f\u75c5\u30fb\u30ea\u30a6\u30de\u30c1\u4e00\u4eba\u6284\u8aad\u4f1a\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","provider_url":"https://hatena.blog","width":"100%","blog_url":"https://ctd-gim.hatenablog.com/","description":"\"Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus : A Randomized Controlled Trial.\u201d Ann Intern Med. 2021;10.7326/M21-2078. doi:10.7326/M21-2078 \u5f93\u6765\u306e\u6cbb\u7642\u306b\u5bfe\u3057\u3066\u62b5\u6297\u6027\u306e\u96e3\u6cbb\u6027SLE\u60a3\u800548\u4eba\u306b\u5bfe\u3057\u3066\u3001Rituximab(\u6297CD20\u6297\u4f53)\u3068Belimumab\uff08BAFF\u4e2d\u548c\u6297\u4f53\uff09\u3068\u3044\u30462\u3064\u306e\u30d0\u30a4\u30aa\u88fd\u5264\u3092\u7d44\u307f\u5408\u308f\u305b\u6295\u4e0e\u3057\u305fRCT 4-8\u9031\u306e\u9593\u306bRitiximab\u3092\uff12\u56de\u6295\u4e0e\u2192\u4ee5\u5f8c\uff11\u5e74\u9593\u30d7\u30e9\u30bb\u30dc or Bel\u2026","version":"1.0","author_url":"https://blog.hatena.ne.jp/CTD_GIM/","provider_name":"Hatena Blog","image_url":null,"height":"190","url":"https://ctd-gim.hatenablog.com/entry/2021/10/27/232028"}